Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Microsoft Corporation

https://www.microsoft.com/en-us/

Latest From Microsoft Corporation

CMR Surgical And Microsoft Collaboration Opens Up Questions About Surgical Data Storage

In a research venture tackling problems in data storage, CMR Surgical and Microsoft have teamed up to trial Microsoft’s new silica product by storing data acquired from CMR Surgical’s Versius robotic surgery system.

Digital Health Artificial Intelligence

Market Intel: Medtechs, Surgeons Embrace ‘Virtual Operating Theater’ As New Reality

In this first part of a three-part series on the “Future of Surgery” we introduce three companies that developed telehealth platforms allowing for virtual collaborations during live surgeries. The second part will discuss AI, VR and AR in the OR.

Market Intelligence Telehealth

NASS 2020: Neurosurgeons Discuss New Technologies For Spine Surgery – Robotics, Navigation, 3D Printing, AR

In a panel discussion, neurosurgeons forecast a bright future for robotics spine surgery and a wish list for technological improvements. 

Neurology Robotic Surgery

Biopharma Quarterly Deal Statistics, Q2 2012

Follow-on public offerings continued to dominate, with 19 transactions making up almost half of Q2’s $2.7 billion financing volume. M&A dollars, up nearly four times that of Q1, totaled $34.7 billion, for 28 completed transactions, seven of which topped the billion dollar mark. In alliances, the Q2 potential deal value – also largely increased over the previous quarter’s – marked possibly the highest amount ever seen along with maybe the most expensive deal ever: Walgreen $6.6 billion agreement to purchase a minority equity share in Alliance Boots, bringing in over half of Q2’s value.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Miscellaneous
UsernamePublicRestriction

Register